Skip to main content
Figure 5 | Virology Journal

Figure 5

From: A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus

Figure 5

Expression of TLR2 in splenocytes of different vaccinated groups on day 2 after infection with S . aureus . (A) Western blot detection of TLR2 in splenocytes. Lane A: PBS group; lane B pEGFP-C2 group; lane C pEGFP /HA2 group; lane D pEGFP/Ag85A group; lane E pEGFP/Ag85A-HA2 group; lane F iPR group. (B) RT-PCR detection of TLR2 in splenocytes. Lanes 1, 8: pEGFP/Ag85A-HA2 group; lanes 2, 9: pEGFP-C2 group; lanes 3, 10: pEGFP /HA2 group; lanes 4, 11: pEGFP/Ag85A group; lanes 5, 12: PBS group; lanes 7, 13: iPR group. Lanes 1–5, 7: TLR2 (410 bp); lanes 8–13: GADPH (531 bp); lanes 6, 14: marker.

Back to article page